What inherited syndromes cause gastric polyps?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Inherited Syndromes Causing Gastric Polyps

The primary inherited syndromes that cause gastric polyps are Familial Adenomatous Polyposis (FAP), Attenuated FAP, Peutz-Jeghers Syndrome, Juvenile Polyposis Syndrome, and PTEN Hamartoma Tumor Syndrome. 1

Adenomatous Polyposis Syndromes with Gastric Involvement

Familial Adenomatous Polyposis (FAP)

  • Causes gastric adenomatous polyps (AP) and cystic fundic gland polyps in patients with hundreds to thousands of colorectal polyps 1
  • Due to germline mutations in the APC gene (autosomal dominant inheritance) 1
  • Gastric polyps occur alongside duodenal adenomatous polyps 1
  • Associated extracolonic features include CHRPE (congenital hypertrophy of retinal pigment epithelium), osteomas, dental anomalies, fibromas, epidermoid cysts, and desmoid tumors 1

Attenuated Familial Adenomatous Polyposis (AFAP)

  • Presents with gastric AP and cystic fundic gland polyps similar to classic FAP but with fewer colorectal polyps (10-100) 1
  • Also caused by APC gene mutations but with different mutation locations leading to milder phenotype 1
  • Same gastric polyp types as classic FAP 1

MUTYH-Associated Polyposis (MAP)

  • Produces gastric AP and cystic fundic gland polyps 1
  • Caused by biallelic mutations in MUTYH gene (autosomal recessive inheritance) 1
  • Typically presents with few to hundreds of colorectal polyps 1

Hamartomatous Polyposis Syndromes with Gastric Involvement

Peutz-Jeghers Syndrome (PJS)

  • Causes hamartomatous polyps in the stomach and throughout the GI tract 1
  • Due to germline mutations in STK11 gene (autosomal dominant) 1
  • Gastric polyps occur alongside small intestine involvement 1
  • Distinctive mucocutaneous hyperpigmentation on buccal mucosa, palms, soles of feet, and periorbital regions 1
  • Carries increased risk of gastric cancer along with multiple other malignancies 1

Juvenile Polyposis Syndrome (JPS)

  • Produces juvenile hamartomatous polyps in the stomach in addition to colorectal involvement 1
  • Caused by mutations in BMPR1A or SMAD4 genes (autosomal dominant) 1
  • Presents with few to hundreds of polyps 1
  • 21% risk of gastric cancer in those with gastric polyps 1
  • If SMAD4 mutation present, may have hereditary hemorrhagic telangiectasia (HHT) overlap with risk of CNS, lung, and GI tract arteriovenous malformations 1

PTEN Hamartoma Tumor Syndrome (PHTS)

  • Includes gastric juvenile polyposis-type polyps along with hyperplastic and adenomatous polyps 1
  • Due to PTEN gene mutations (autosomal dominant); rarely BMPR1A mutations 1
  • Associated with trichilemmomas, ganglioneuromas, macrocephaly, autism spectrum disorders, and mucocutaneous hamartomas 1
  • Gastric and colorectal involvement documented 1

Additional Syndromes with Gastric Polyp Potential

Hereditary Mixed Polyposis Syndrome (HMPS)

  • May involve gastric polyps though specific gastric involvement is less well-characterized 1
  • Caused by GREM1 or BMPR1A gene mutations (autosomal dominant) 1
  • Presents with hyperplastic and adenomatous polyps 1

Clinical Recognition Pitfalls

Key diagnostic considerations:

  • FAP/AFAP patients with gastric polyps will have cystic fundic gland polyps as the hallmark gastric finding alongside adenomatous polyps 1
  • PJS mucocutaneous pigmentation may fade with age and be absent in adults, so absence does not exclude diagnosis 1
  • JPS gastric polyps specifically confer 21% gastric cancer risk, making surveillance critical 1
  • Solitary juvenile polyps in children are common and not associated with cancer risk, unlike syndromic juvenile polyposis 1
  • SMAD4 mutations in JPS require evaluation for HHT-related vascular malformations 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.